产品特点
Issued: April 2013
AN: 01879/2011
:
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Marfloxin 5 mg tablets for cats and dogs
Quiflox 5 mg tablets for cats and dogs
Quiflox vet 5 mg tablets for cats and dogs
Marbiflox 5 mg tablets for cats and dogs
Marfloxin 5 mg tablets for cats and dogs (Austria, Belgium, Bulgaria, Estonia,
Germany, Greece, Italy, Ireland, Netherlands, Poland, Portugal, Romania, Slovenia,
Spain, United Kingdom)
Quiflox 5 mg tablets for cats and dogs (Czech Republic, Hungary, Latvi a, Lithuania,
Slovak Republic)
Quiflox vet 5 mg tablets for cats and dogs (Finland, Sweden, Norway)
Marbiflox 5 mg tablets for cats and dogs(Denmark, France,)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE:
Marbofloxacin…….5 mg
EXCIPIENTS:
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablets.
Light brownish yellow, round, biconvex, marble tablets with bevelled edges and with
possible dark and white spots, scored on one side.
The tablets can be divided into halves.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats and dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of infections caused by strains of microorganisms susceptible to
marbofloxacin.
Issued: April 2013
AN: 01879/2011
:
Page 2 of 6
In dogs:
skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis,
furunculosis, cellulitis);
urinary tract infections (UTI) associated or not with prostatitis or epididymitis;
阅读完整的文件